Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial
Abstract Aims Dipeptidyl peptidase 3 (DPP3) is a protease involved in the degradation of
cardiovascular mediators. Its administration has been shown to be associated with impaired …
cardiovascular mediators. Its administration has been shown to be associated with impaired …
[引用][C] Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial
K Takagi, A Blet, B Levy, B Deniau, F Azibani… - European Journal of …, 2020 - hal.science
Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock:
results from the OptimaCC trial - Archive ouverte HAL Accéder directement au contenu …
results from the OptimaCC trial - Archive ouverte HAL Accéder directement au contenu …
[PDF][PDF] Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial
K Takagi, A Blet, B Levy, B Deniau, F Azibani, E Feliot… - 2019 - dbi-ag.de
Aims Dipeptidyl peptidase 3 (DPP3) is a protease involved in the degradation of
cardiovascular mediators. Its administration has been shown to be associated with impaired …
cardiovascular mediators. Its administration has been shown to be associated with impaired …
[PDF][PDF] Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial
K Takagi, A Blet, B Levy, B Deniau, F Azibani, E Feliot… - 2019 - researchgate.net
Aims Dipeptidyl peptidase 3 (DPP3) is a protease involved in the degradation of
cardiovascular mediators. Its administration has been shown to be associated with impaired …
cardiovascular mediators. Its administration has been shown to be associated with impaired …
Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial
K Takagi, A Blet, B Levy, B Deniau, F Azibani, E Feliot… - 2020 - pubmed.ncbi.nlm.nih.gov
Aims Dipeptidyl peptidase 3 (DPP3) is a protease involved in the degradation of
cardiovascular mediators. Its administration has been shown to be associated with impaired …
cardiovascular mediators. Its administration has been shown to be associated with impaired …
Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial.
K Takagi, A Blet, B Levy, B Deniau… - European Journal of …, 2019 - europepmc.org
Aims Dipeptidyl peptidase 3 (DPP3) is a protease involved in the degradation of
cardiovascular mediators. Its administration has been shown to be associated with impaired …
cardiovascular mediators. Its administration has been shown to be associated with impaired …